Researchers find tree inequity for communities of color fox9.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fox9.com Daily Mail and Mail on Sunday newspapers.
It may seem like all eyes are on the Derek Chauvin Trial, but who isn t watching and why?
Watching the court proceedings can be so retraumatizing for Black Americans that doctors say it s a health risk factor.
Credit: KARE 11 Published: 4:43 PM CDT April 19, 2021 Updated: 4:43 PM CDT April 19, 2021
MINNEAPOLIS It may feel like all eyes are on the Derek Chauvin trial and as we await the verdict, but some people are choosing not to watch it all unfold. For some, it has to do with the real health risk that they face.
When KARE 11 normally interviews Zeke McKinney, it s because he s an occupational medicine doctor studying the Astra-Zeneca vaccine.
Many doctors warn against comparing the efficacy of all the vaccines. In terms of effectiveness, I don t know that I like any one better than the other because they all work pretty good, explained Dr. McKinney. I still think we have a long way to go to understand the difference between pretty good and super great.
Unlike the Pfizer vaccine, AstraZeneca can be stored in normal refrigerators, making it cheaper too. Dr. McKinney also thinks it could get FDA approval next month. Regulators in Canada gave it a go on Friday.
The potential supply increase had President Biden predicting Thursday that any adult who wanted a vaccine could get one in one to three months. Minnesota health officials are hoping the general public would have access to the vaccines by summer.
Minnesota s latest timeline for COVID-19 vaccinations kare11.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kare11.com Daily Mail and Mail on Sunday newspapers.
Healthcare industry reaching out to vaccine-hesitant communities of color
(FOX 9) - With distribution of a coronavirus vaccine expected this spring, one challenge facing the healthcare industry is that some communities may be hard to reach.
Studies show that communities of color, particularly Black Americans, are hesitant to take the COVID-19 vaccine. Right now, there’s an effort underway to build trust.
Healthcare industry reaching out to vaccine-hesitant communities of color
Studies show that communities of color, particularly Black Americans are hesitant to take a COVID-19 vaccine. Right now, there’s an effort underway to help build trust.
“I got my first injection last Friday and I’m happy to say that I’m doing fine,” said Adriene Thornton, who is taking part in a COVID-19 vaccine trial.